{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["active cancer targeting", "cancer cell", "co-delivery system", "curcumin combined colchicine core-shell nanoformulation", "functionalized mesoporous silica nanoparticle", "natural agent"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36559264", "DateRevised": {"Year": "2023", "Month": "03", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "11"}], "Language": ["eng"], "ELocationID": ["2770", "10.3390/pharmaceutics14122770"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "14", "Issue": "12", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "11"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Co-Delivery System of Curcumin and Colchicine Using Functionalized Mesoporous Silica Nanoparticles Promotes Anticancer and Apoptosis Effects.", "Abstract": {"AbstractText": ["Purpose: Many natural agents have a high anticancer potential, and their combination may be advantageous for improved anticancer effects. Such agents, however, often are not water soluble and do not efficiently target cancer cells, and the kinetics of their action is poorly controlled. One way to overcome these barriers is to combine natural agents with nanoparticles. Our aim in the current study was to fabricate an anticancer nanoformulation for co-delivery of two natural agents, curcumin (CR) and colchicine (CL), with a core-shell structure. Using cancer cell lines, we compared the anticancer efficacy between the combination and a nanoformulation with CL alone. Methods: For the single-drug nanoformulation, we used phosphonate groups to functionalize mesoporous silica nanoparticles (MSNs) and loaded the MSNs with CL. Additional loading of this nanoformulation with CR achieved the co-delivery format. To create the structure with a core shell, we selected a chitosan\u2212cellulose mixture conjugated with targeting ligands of folic acid for the coating. For evaluating anticancer and apoptosis effects, we assessed changes in important genes and proteins in apoptosis (p53, caspase-3, Bax, Bcl-2) in several cell lines (MCF-7, breast adenocarcinoma; HCT-116, colon carcinoma; HOS, human osteosarcoma; and A-549, non\u2212small cell lung cancer). Results: Nanoformulations were successfully synthesized and contained 10.9 wt.% for the CL single-delivery version and 18.1 wt.% for the CL+CR co-delivery nanoformulation. Anticancer effects depended on treatment, cell line, and concentration. Co-delivery nanoformulations exerted anticancer effects that were significantly superior to those of single delivery or free CL or CR. Anticancer effects by cell line were in the order of HCT-116 > A549 > HOS > MCF-7. The lowest IC50 value was obtained for the nanoformulation consisting of CL and CR coated with a polymeric shell conjugated with FA (equivalent to 4.1 \u00b1 0.05 \u00b5g/mL). With dual delivery compared with the free agents, we detected strongly increased p53, caspase-3, and Bax expression, but inhibition of Bcl-2, suggesting promotion of apoptosis. Conclusions: Our findings, although preliminary, indicate that the proposed dual delivery nanoformulation consisting of nanocore: MSNs loaded with CL and CR and coated with a shell of chitosan\u2212cellulose conjugated folic acid exerted strong anticancer and apoptotic effects with potent antitumor activity against HCT-116 colon cells. The effect bested CL alone. Evaluating and confirming the efficacy of co-delivery nanoformulations will require in vivo studies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre (NRC), 33 El-Behouth Street, Dokki, Giza 12622, Egypt."}], "LastName": "AbouAitah", "ForeName": "Khaled", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Bioassay-Cell Culture Laboratory, Pharmacognosy Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre (NRC), 33 El-Behouth St, Dokki, Giza 12622, Egypt."}], "LastName": "Soliman", "ForeName": "Ahmed A F", "Initials": "AAF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Swiderska-Sroda", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Department, Faculty of Agriculture, Cairo University, Giza 12613, Egypt."}], "LastName": "Nassrallah", "ForeName": "Amr", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Semiconductor Characterization, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Smalc-Koziorowska", "ForeName": "Julita", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Gierlotka", "ForeName": "Stanislaw", "Initials": "S"}, {"Identifier": ["0000-0001-8521-0688"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Lojkowski", "ForeName": "Witold", "Initials": "W"}], "GrantList": [{"GrantID": "(STRATEGMED3/306888/3/NCBR/2017, project iTE, Poland)", "Agency": "This work was partially supported by the National Center for Research and Development, Poland", "Country": ""}, {"GrantID": "(RPMA.01.01.00-14-8476/17-04)", "Agency": "The research studies were conducted using equipment funded by the Center for Preclinical Research and Technology -CePT II (RPMA.01.01.00-14-8476/17-04) from the Regional Operational Pro-gramme of the Mazowieckie Voivodeship 2014-2020.", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Vinciguerra D., Jacobs M., Denis S., Mougin J., Guillaneuf Y., Lazzari G., Zhu C., Mura S., Couvreur P., Nicolas J. Heterotelechelic polymer prodrug nanoparticles: Adaptability to different drug combinations and influence of the dual functionalization on the cytotoxicity. J. Control. Release. 2019;295:223\u2013236. doi: 10.1016/j.jconrel.2018.12.047.", "ArticleIdList": ["10.1016/j.jconrel.2018.12.047", "30611900"]}, {"Citation": "Hu C.M., Zhang L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem. Pharmacol. 2012;83:1104\u20131111. doi: 10.1016/j.bcp.2012.01.008.", "ArticleIdList": ["10.1016/j.bcp.2012.01.008", "22285912"]}, {"Citation": "Qi S.S., Sun J.H., Yu H.H., Yu S.Q. Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy. Drug Deliv. 2017;24:1909\u20131926. doi: 10.1080/10717544.2017.1410256.", "ArticleIdList": ["10.1080/10717544.2017.1410256", "PMC8241150", "29191057"]}, {"Citation": "Hu C.M., Aryal S., Zhang L. Nanoparticle-assisted combination therapies for effective cancer treatment. Ther. Deliv. 2010;1:323\u2013334. doi: 10.4155/tde.10.13.", "ArticleIdList": ["10.4155/tde.10.13", "22816135"]}, {"Citation": "Zhang D., Kong Y.Y., Sun J.H., Huo S.J., Zhou M., Gui Y.L., Mu X., Chen H., Yu S.Q., Xu Q. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance. Int. J. Nanomed. 2017;12:2081\u20132108. doi: 10.2147/IJN.S128790.", "ArticleIdList": ["10.2147/IJN.S128790", "PMC5360411", "28356731"]}, {"Citation": "Greco F., Vicent M.J. Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv. Drug Deliv. Rev. 2009;61:1203\u20131213. doi: 10.1016/j.addr.2009.05.006.", "ArticleIdList": ["10.1016/j.addr.2009.05.006", "19699247"]}, {"Citation": "Parhi P., Mohanty C., Sahoo S.K. Nanotechnology-based combinational drug delivery: An emerging approach for cancer therapy. Drug Discov. Today. 2012;17:1044\u20131052. doi: 10.1016/j.drudis.2012.05.010.", "ArticleIdList": ["10.1016/j.drudis.2012.05.010", "22652342"]}, {"Citation": "Wang H., Zhao Y., Wu Y., Hu Y.L., Nan K., Nie G., Chen H. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials. 2011;32:8281\u20138290. doi: 10.1016/j.biomaterials.2011.07.032.", "ArticleIdList": ["10.1016/j.biomaterials.2011.07.032", "21807411"]}, {"Citation": "Jiang H., Geng D., Liu H., Li Z., Cao J. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Drug Deliv. 2016;23:3665\u20133673. doi: 10.1080/10717544.2016.1217954.", "ArticleIdList": ["10.1080/10717544.2016.1217954", "27749102"]}, {"Citation": "AbouAitah K., Swiderska-Sroda A., Farghali A.A., Wojnarowicz J., Stefanek A., Gierlotka S., Opalinska A., Allayeh A.K., Ciach T., Lojkowski W. Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action. Oncotarget. 2018;9:26466\u201326490. doi: 10.18632/oncotarget.25470.", "ArticleIdList": ["10.18632/oncotarget.25470", "PMC5995188", "29899871"]}, {"Citation": "AbouAitah K., Hassan H.A., Swiderska-Sroda A., Gohar L., Shaker O.G., Wojnarowicz J., Opalinska A., Smalc-Koziorowska J., Gierlotka S., Lojkowski W. Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles. Cancers. 2020;12:144. doi: 10.3390/cancers12010144.", "ArticleIdList": ["10.3390/cancers12010144", "PMC7017376", "31936103"]}, {"Citation": "Shahein S.A., Aboul-Enein A.M., Higazy I.M., Abou-Elella F., Lojkowski W., Ahmed E.R., Mousa S.A., AbouAitah K. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release. Int. J. Nanomed. 2019;14:5503\u20135526. doi: 10.2147/IJN.S206899.", "ArticleIdList": ["10.2147/IJN.S206899", "PMC6650459", "31410001"]}, {"Citation": "Gao Y., Gao D., Shen J., Wang Q. A Review of Mesoporous Silica Nanoparticle Delivery Systems in Chemo-Based Combination Cancer Therapies. Front. Chem. 2020;8:598722. doi: 10.3389/fchem.2020.598722.", "ArticleIdList": ["10.3389/fchem.2020.598722", "PMC7732422", "33330389"]}, {"Citation": "Zhang Y., Hou Z., Ge Y., Deng K., Liu B., Li X., Li Q., Cheng Z., Ma P., Li C., et al. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery. ACS Appl. Mater. Interfaces. 2015;7:20696\u201320706. doi: 10.1021/acsami.5b05522.", "ArticleIdList": ["10.1021/acsami.5b05522", "26325285"]}, {"Citation": "Wang L., Guan H., Wang Z., Xing Y., Zhang J., Cai K. Hybrid Mesoporous\u2013Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery. Mol. Pharm. 2018;15:2503\u20132512. doi: 10.1021/acs.molpharmaceut.7b01096.", "ArticleIdList": ["10.1021/acs.molpharmaceut.7b01096", "29768014"]}, {"Citation": "Wang S., Liu X., Chen S., Liu Z., Zhang X., Liang X.-J., Li L. Regulation of Ca2+ Signaling for Drug-Resistant Breast Cancer Therapy with Mesoporous Silica Nanocapsule Encapsulated Doxorubicin/siRNA Cocktail. ACS Nano. 2019;13:274\u2013283. doi: 10.1021/acsnano.8b05639.", "ArticleIdList": ["10.1021/acsnano.8b05639", "30566319"]}, {"Citation": "Xing Y., Zhou Y., Zhang Y., Zhang C., Deng X., Dong C., Shuang S. Facile Fabrication Route of Janus Gold-Mesoporous Silica Nanocarriers with Dual-Drug Delivery for Tumor Therapy. ACS Biomater. Sci. Eng. 2020;6:1573\u20131581. doi: 10.1021/acsbiomaterials.0c00042.", "ArticleIdList": ["10.1021/acsbiomaterials.0c00042", "33455359"]}, {"Citation": "Weinstein S.J., Hartman T.J., Stolzenberg-Solomon R., Pietinen P., Barrett M.J., Taylor P.R., Virtamo J., Albanes D. Null association between prostate cancer and serum folate, vitamin B6, vitamin B12, and homocysteine. Cancer Epidemiol. Biomark. Prev. 2003;12:1271\u20131272.", "ArticleIdList": ["14652294"]}, {"Citation": "Lu Y., Low P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 2002;54:675\u2013693. doi: 10.1016/S0169-409X(02)00042-X.", "ArticleIdList": ["10.1016/S0169-409X(02)00042-X", "12204598"]}, {"Citation": "Porta F., Lamers G.E., Morrhayim J., Chatzopoulou A., Schaaf M., den Dulk H., Backendorf C., Zink J.I., Kros A. Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery. Adv. Healthc. Mater. 2013;2:281\u2013286. doi: 10.1002/adhm.201200176.", "ArticleIdList": ["10.1002/adhm.201200176", "23184490"]}, {"Citation": "Al-Nadaf A.H., Dahabiyeh L.A., Jawarneh S., Bardaweel S., Mahmoud N.N. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery. Pharm. Dev. Technol. 2021;26:582\u2013591. doi: 10.1080/10837450.2021.1904258.", "ArticleIdList": ["10.1080/10837450.2021.1904258", "33729906"]}, {"Citation": "Tan B.L., Norhaizan M.E. Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer. Molecules. 2019;24:2527. doi: 10.3390/molecules24142527.", "ArticleIdList": ["10.3390/molecules24142527", "PMC6680685", "31295906"]}, {"Citation": "Bollu V.S., Barui A.K., Mondal S.K., Prashar S., Fajardo M., Briones D., Rodr\u00edguez-Di\u00e9guez A., Patra C.R., G\u00f3mez-Ruiz S. Curcumin-loaded silica-based mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells. Mater. Sci. Eng. C. 2016;63:393\u2013410. doi: 10.1016/j.msec.2016.03.011.", "ArticleIdList": ["10.1016/j.msec.2016.03.011", "27040234"]}, {"Citation": "Chen S., Liang Q., Xie S., Liu E., Yu Z., Sun L., Shin M.C., Lee S.J., He H., Yang V.C. Curcumin based combination therapy for anti-breast cancer: From in vitro drug screening to in vivo efficacy evaluation. Front. Chem. Sci. Eng. 2016;10:383\u2013388. doi: 10.1007/s11705-016-1574-2.", "ArticleIdList": ["10.1007/s11705-016-1574-2"]}, {"Citation": "Zhao X., Chen Q., Li Y., Tang H., Liu W., Yang X. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur. J. Pharm. Biopharm. 2015;93:27\u201336. doi: 10.1016/j.ejpb.2015.03.003.", "ArticleIdList": ["10.1016/j.ejpb.2015.03.003", "25770771"]}, {"Citation": "Ni W., Li Z., Liu Z., Ji Y., Wu L., Sun S., Jian X., Gao X. Dual-Targeting Nanoparticles: Codelivery of Curcumin and 5-Fluorouracil for Synergistic Treatment of Hepatocarcinoma. J. Pharm. Sci. 2019;108:1284\u20131295. doi: 10.1016/j.xphs.2018.10.042.", "ArticleIdList": ["10.1016/j.xphs.2018.10.042", "30395829"]}, {"Citation": "Bayet-Robert M., Kwiatkowski F., Leheurteur M., Gachon F., Planchat E., Abrial C., Mouret-Reynier M.A., Durando X., Barthomeuf C., Chollet P. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol. Ther. 2010;9:8\u201314. doi: 10.4161/cbt.9.1.10392.", "ArticleIdList": ["10.4161/cbt.9.1.10392", "19901561"]}, {"Citation": "Epelbaum R., Schaffer M., Vizel B., Badmaev V., Bar-Sela G. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr. Cancer. 2010;62:1137\u20131141. doi: 10.1080/01635581.2010.513802.", "ArticleIdList": ["10.1080/01635581.2010.513802", "21058202"]}, {"Citation": "Ghalaut V.S., Sangwan L., Dahiya K., Ghalaut P.S., Dhankhar R., Saharan R. Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia. J. Oncol. Pharm. Pract. 2012;18:186\u2013190. doi: 10.1177/1078155211416530.", "ArticleIdList": ["10.1177/1078155211416530", "21844132"]}, {"Citation": "James M.I., Iwuji C., Irving G., Karmokar A., Higgins J.A., Griffin-Teal N., Thomas A., Greaves P., Cai H., Patel S.R., et al. Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. Cancer Lett. 2015;364:135\u2013141. doi: 10.1016/j.canlet.2015.05.005.", "ArticleIdList": ["10.1016/j.canlet.2015.05.005", "PMC4510144", "25979230"]}, {"Citation": "Bhattacharyya B., Panda D., Gupta S., Banerjee M. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin. Med. Res. Rev. 2008;28:155\u2013183. doi: 10.1002/med.20097.", "ArticleIdList": ["10.1002/med.20097", "17464966"]}, {"Citation": "Huang Z., Xu Y., Peng W. Colchicine induces apoptosis in HT-29 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways. Mol. Med. Rep. 2015;12:5939\u20135944. doi: 10.3892/mmr.2015.4222.", "ArticleIdList": ["10.3892/mmr.2015.4222", "26299305"]}, {"Citation": "Zhang L., Yang Z., Granieri L., Pasculescu A., Datti A., Asa S.L., Xu Z., Ezzat S. High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor. Oncotarget. 2016;7:19948\u201319959. doi: 10.18632/oncotarget.7890.", "ArticleIdList": ["10.18632/oncotarget.7890", "PMC4991430", "26942566"]}, {"Citation": "Cho J.H., Joo Y.H., Shin E.Y., Park E.J., Kim M.S. Anticancer Effects of Colchicine on Hypopharyngeal Cancer. Anticancer Res. 2017;37:6269\u20136280. doi: 10.21873/anticanres.12078.", "ArticleIdList": ["10.21873/anticanres.12078", "29061810"]}, {"Citation": "Lin Z.Y., Kuo C.H., Wu D.C., Chuang W.L. Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines. Kaohsiung J. Med. Sci. 2016;32:68\u201373. doi: 10.1016/j.kjms.2015.12.006.", "ArticleIdList": ["10.1016/j.kjms.2015.12.006", "26944324"]}, {"Citation": "Aboul-Soud M.A.M., Al-Amri M.Z., Kumar A., Al-Sheikh Y.A., Ashour A.E., El-Kersh T.A. Specific Cytotoxic Effects of Parasporal Crystal Proteins Isolated from Native Saudi Arabian Bacillus thuringiensis Strains against Cervical Cancer Cells. Molecules. 2019;24:506. doi: 10.3390/molecules24030506.", "ArticleIdList": ["10.3390/molecules24030506", "PMC6384957", "30708936"]}, {"Citation": "El-Hallouty S.M., Soliman A.A.F., Nassrallah A., Salamatullah A., Alkaltham M.S., Kamal K.Y., Hanafy E.A., Gaballa H.S., Aboul-Soud M.A.M. Crude Methanol Extract of Rosin Gum Exhibits Specific Cytotoxicity against Human Breast Cancer Cells via Apoptosis Induction. Anticancer Agents Med. Chem. 2020;20:1028\u20131036. doi: 10.2174/1871520620666200423074826.", "ArticleIdList": ["10.2174/1871520620666200423074826", "32324522"]}, {"Citation": "Assaad H.I., Zhou L., Carroll R.J., Wu G. Rapid publication-ready MS-Word tables for one-way ANOVA. SpringerPlus. 2014;3:474. doi: 10.1186/2193-1801-3-474.", "ArticleIdList": ["10.1186/2193-1801-3-474", "PMC4153873", "25191639"]}, {"Citation": "AbouAitah K., Swiderska-Sroda A., Kandeil A., Salman A.M.M., Wojnarowicz J., Ali M.A., Opalinska A., Gierlotka S., Ciach T., Lojkowski W. Virucidal Action Against Avian Influenza H5N1 Virus and Immunomodulatory Effects of Nanoformulations Consisting of Mesoporous Silica Nanoparticles Loaded with Natural Prodrugs. Int. J. Nanomed. 2020;15:5181\u20135202. doi: 10.2147/IJN.S247692.", "ArticleIdList": ["10.2147/IJN.S247692", "PMC7398888", "32801685"]}, {"Citation": "Langer R., Tirrell D.A. Designing materials for biology and medicine. Nature. 2004;428:487\u2013492. doi: 10.1038/nature02388.", "ArticleIdList": ["10.1038/nature02388", "15057821"]}, {"Citation": "Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat. Rev. Drug Discov. 2008;7:771\u2013782. doi: 10.1038/nrd2614.", "ArticleIdList": ["10.1038/nrd2614", "18758474"]}, {"Citation": "Alexis F., Pridgen E.M., Langer R., Farokhzad O.C. Drug Delivery. Volume 197. Springer; Berlin/Heidelberg, Germany: 2010. Nanoparticle technologies for cancer therapy; pp. 55\u201386. Handbook of Experimental Pharmacology.", "ArticleIdList": ["10.1007/978-3-642-00477-3_2", "20217526"]}, {"Citation": "Mossenta M., Busato D., Dal Bo M., Macor P., Toffoli G. Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies. Int. J. Mol. Sci. 2022;23:10038. doi: 10.3390/ijms231710038.", "ArticleIdList": ["10.3390/ijms231710038", "PMC9456072", "36077433"]}, {"Citation": "Guo X., Guo N., Zhao J., Cai Y. Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells. Oncol. Rep. 2017;38:1442\u20131450. doi: 10.3892/or.2017.5829.", "ArticleIdList": ["10.3892/or.2017.5829", "PMC5549023", "28731164"]}, {"Citation": "Yan J., Xu X., Zhou J., Liu C., Zhang L., Wang D., Yang F., Zhang H. Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery. ACS Appl. Bio Mater. 2020;3:1216\u20131225. doi: 10.1021/acsabm.9b01111.", "ArticleIdList": ["10.1021/acsabm.9b01111", "35019322"]}, {"Citation": "Liang Y., Liu Z.-Y., Wang P.-Y., Li Y.-J., Wang R.-R., Xie S.-Y. Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant. J. Control. Release. 2021;336:396\u2013409. doi: 10.1016/j.jconrel.2021.06.034.", "ArticleIdList": ["10.1016/j.jconrel.2021.06.034", "34175367"]}, {"Citation": "Lin J., Cai Q., Tang Y., Xu Y., Wang Q., Li T., Xu H., Wang S., Fan K., Liu Z., et al. PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect. Int. J. Pharm. 2018;536:272\u2013282. doi: 10.1016/j.ijpharm.2017.10.043.", "ArticleIdList": ["10.1016/j.ijpharm.2017.10.043", "29079221"]}, {"Citation": "Gali-Muhtasib H., Hmadi R., Kareh M., Tohme R., Darwiche N. Cell death mechanisms of plant-derived anticancer drugs: Beyond apoptosis. Apoptosis. 2015;20:1531\u20131562. doi: 10.1007/s10495-015-1169-2.", "ArticleIdList": ["10.1007/s10495-015-1169-2", "26362468"]}, {"Citation": "Mirzaei H., Shakeri A., Rashidi B., Jalili A., Banikazemi Z., Sahebkar A. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomed. Pharmacother. 2017;85:102\u2013112. doi: 10.1016/j.biopha.2016.11.098.", "ArticleIdList": ["10.1016/j.biopha.2016.11.098", "27930973"]}, {"Citation": "Yan L., Huang H., Zhang Y., Yuan X., Yan Z., Cao C., Luo X. Involvement of p53-dependent apoptosis signal in antitumor effect of Colchicine on human papilloma virus (HPV)-positive human cervical cancer cells. Biosci. Rep. 2020;40:BSR20194065. doi: 10.1042/BSR20194065.", "ArticleIdList": ["10.1042/BSR20194065", "PMC7098170", "32163135"]}, {"Citation": "Yang J., Ning J., Peng L., He D. Effect of curcumin on Bcl-2 and Bax expression in nude mice prostate cancer. Int. J. Clin. Exp. Pathol. 2015;8:9272\u20139278.", "ArticleIdList": ["PMC4583908", "26464676"]}, {"Citation": "Wu C., Sun X., Zhao Z., Zhao Y., Hao Y., Liu Y., Gao Y. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs. Mater. Sci. Eng. C Mater. Biol. Appl. 2014;44:262\u2013267. doi: 10.1016/j.msec.2014.08.040.", "ArticleIdList": ["10.1016/j.msec.2014.08.040", "25280705"]}, {"Citation": "L\u00f6bmann K., Laitinen R., Grohganz H., Gordon K.C., Strachan C., Rades T. Coamorphous drug systems: Enhanced physical stability and dissolution rate of indomethacin and naproxen. Mol. Pharm. 2011;8:1919\u20131928. doi: 10.1021/mp2002973.", "ArticleIdList": ["10.1021/mp2002973", "21815614"]}, {"Citation": "Ali O.M., Bekhit A.A., Khattab S.N., Helmy M.W., Abdel-Ghany Y.S., Teleb M., Elzoghby A.O. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy. Colloids Surf. B Biointerfaces. 2020;188:110824. doi: 10.1016/j.colsurfb.2020.110824.", "ArticleIdList": ["10.1016/j.colsurfb.2020.110824", "32023511"]}, {"Citation": "Villanueva A., Canete M., Roca A.G., Calero M., Veintemillas-Verdaguer S., Serna C.J., Morales Mdel P., Miranda R. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology. 2009;20:115103. doi: 10.1088/0957-4484/20/11/115103.", "ArticleIdList": ["10.1088/0957-4484/20/11/115103", "19420433"]}, {"Citation": "Yue Z.-G., Wei W., Lv P.-P., Yue H., Wang L.-Y., Su Z.-G., Ma G.-H. Surface Charge Affects Cellular Uptake and Intracellular Trafficking of Chitosan-Based Nanoparticles. Biomacromolecules. 2011;12:2440\u20132446. doi: 10.1021/bm101482r.", "ArticleIdList": ["10.1021/bm101482r", "21657799"]}, {"Citation": "Liu Q., Zhang J., Sun W., Xie Q.R., Xia W., Gu H. Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. Int. J. Nanomed. 2012;7:999\u20131013. doi: 10.2147/ijn.s28088.", "ArticleIdList": ["10.2147/ijn.s28088", "PMC3292423", "22403484"]}, {"Citation": "Fang J., Zhang S., Xue X., Zhu X., Song S., Wang B., Jiang L., Qin M., Liang H., Gao L. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy. Int. J. Nanomed. 2018;13:5113\u20135126. doi: 10.2147/IJN.S170862.", "ArticleIdList": ["10.2147/IJN.S170862", "PMC6135215", "30233175"]}, {"Citation": "Hengartner M.O. The biochemistry of apoptosis. Nature. 2000;407:770\u2013776. doi: 10.1038/35037710.", "ArticleIdList": ["10.1038/35037710", "11048727"]}, {"Citation": "Johnstone R.W., Ruefli A.A., Lowe S.W. Apoptosis: A link between cancer genetics and chemotherapy. Cell. 2002;108:153\u2013164. doi: 10.1016/S0092-8674(02)00625-6.", "ArticleIdList": ["10.1016/S0092-8674(02)00625-6", "11832206"]}, {"Citation": "Lowe S.W., Lin A.W. Apoptosis in cancer. Carcinogenesis. 2000;21:485\u2013495. doi: 10.1093/carcin/21.3.485.", "ArticleIdList": ["10.1093/carcin/21.3.485", "10688869"]}, {"Citation": "McIlwain D.R., Berger T., Mak T.W. Caspase functions in cell death and disease. Cold Spring Harb. Perspect. Biol. 2013;5:a008656. doi: 10.1101/cshperspect.a008656.", "ArticleIdList": ["10.1101/cshperspect.a008656", "PMC3683896", "23545416"]}, {"Citation": "Thornberry N.A. Caspases: Key mediators of apoptosis. Chem. Biol. 1998;5:R97\u2013R103. doi: 10.1016/S1074-5521(98)90615-9.", "ArticleIdList": ["10.1016/S1074-5521(98)90615-9", "9578633"]}, {"Citation": "Thornberry N.A., Lazebnik Y. Caspases: Enemies within. Science. 1998;281:1312\u20131316. doi: 10.1126/science.281.5381.1312.", "ArticleIdList": ["10.1126/science.281.5381.1312", "9721091"]}, {"Citation": "Hensley P., Mishra M., Kyprianou N. Targeting caspases in cancer therapeutics. Biol. Chem. 2013;394:831\u2013843. doi: 10.1515/hsz-2013-0128.", "ArticleIdList": ["10.1515/hsz-2013-0128", "PMC3721733", "23509217"]}, {"Citation": "Wei C.L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., Shahab A., Yong H.C., Fu Y., Weng Z., et al. A global map of p53 transcription-factor binding sites in the human genome. Cell. 2006;124:207\u2013219. doi: 10.1016/j.cell.2005.10.043.", "ArticleIdList": ["10.1016/j.cell.2005.10.043", "16413492"]}, {"Citation": "Davies C., Hogarth L.A., Mackenzie K.L., Hall A.G., Lock R.B. p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia. Cell Cycle. 2015;14:3602\u20133612. doi: 10.1080/15384101.2015.1100774.", "ArticleIdList": ["10.1080/15384101.2015.1100774", "PMC4825786", "26506264"]}, {"Citation": "Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335:440\u2013442. doi: 10.1038/335440a0.", "ArticleIdList": ["10.1038/335440a0", "3262202"]}, {"Citation": "Scherr A.-L., Gdynia G., Salou M., Radhakrishnan P., Duglova K., Heller A., Keim S., Kautz N., Jassowicz A., Elssner C., et al. Bcl-xL is an oncogenic driver in colorectal cancer. Cell Death Dis. 2016;7:e2342. doi: 10.1038/cddis.2016.233.", "ArticleIdList": ["10.1038/cddis.2016.233", "PMC5108319", "27537525"]}, {"Citation": "Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J.C., Perucho M. Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype. Science. 1997;275:967\u2013969. doi: 10.1126/science.275.5302.967.", "ArticleIdList": ["10.1126/science.275.5302.967", "9020077"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "2"}, {"Year": "2022", "Month": "12", "Day": "3"}, {"Year": "2022", "Month": "12", "Day": "6"}, {"Year": "2022", "Month": "12", "Day": "23", "Hour": "1", "Minute": "57"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["36559264", "PMC9785757", "10.3390/pharmaceutics14122770", "pharmaceutics14122770"]}}], "PubmedBookArticle": []}